Sexually Transmitted Infections (STIs) Industry Report 2025-2034: Market Dynamics, Trends, And Forecasts

The Sexually Transmitted Infections (STIs) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Sexually Transmitted Infections (STIs) Market Size During the Forecast Period?
The market for sexually transmitted infections (STIs) has seen swift growth in the past few years. The market, which is predicted to be worth $63.69 billion in 2024, is set to grow to a value of $71.93 billion in 2025, representing a compound annual growth rate (CAGR) of 12.9%. The growth witnessed in the past period is due largely to factors such as behaviors, education and awareness, access to healthcare and the development of antibiotics.

The market size for sexually transmitted infections (STIs) is predicted to experience swift expansion in the forthcoming years, with an estimated value of $113.38 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.0%. The expected growth in this duration is owed to the emergence of new STI strains, vaccination endeavors, advancement in telemedicine, at-home testing, as well as increased focus on sexual health equity. Significant trends driving the market during this forecast period involve the growing concern of antimicrobial resistance, increased use of pre-exposure prophylaxis (prep), self-care approaches to STIs, and enhanced sex education.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13047

What Are the High-Growth Segments in the Sexually Transmitted Infections (STIs) Market?
The sexually transmitted infections (STIs) market covered in this report is segmented -

1) By Type: Human Immunodeficiency Virus (HIV), Human Papilloma Virus (HPV), Gonorrhea, Syphilis, Other Types
2) By Treatment: Antibiotics, Antiviral
3) By Location Of Testing: Laboratory Testing, Point-Of-Care (POC) Testing
4) By Route Of Administration: Oral, Parenteral, Other Route Of Administration
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users

Subsegments:
1) By Human Immunodeficiency Virus (HIV): HIV Type 1, HIV Type 2
2) By Human Papilloma Virus (HPV): Low-Risk HPV, High-Risk HPV
3) By Gonorrhea: Uncomplicated Gonorrhea, Complicated Gonorrhea
4) By Syphilis: Primary Syphilis, Secondary Syphilis, Tertiary Syphilis
5) By Other Types: Chlamydia, Herpes Simplex Virus (HSV), Hepatitis B, Hepatitis C, Trichomoniasis

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13047&type=smp

What Key Drivers Are Expected to Influence Future Sexually Transmitted Infections (STIs) Market Growth?
Government efforts aimed at enhancing public awareness about sexually transmitted infections (STIs) are projected to boost the growth of the STI market. Government initiatives are usually programs or policies designed to accomplish set targets and address specific problems. Various initiatives have been established by the government to counter and treat STIs. These initiatives include funding public awareness campaigns about STIs, administering vaccines to prevent certain STIs, and offering free or inexpensive STI screening. For example, the US-based public health department, Springfield-Greene County Health, introduced Disease Intervention Specialist (DIS) in April 2023. This program, in collaboration with the Missouri Department of Health and Senior Services (Missouri DHSS), aims to fight against the escalating spread of STIs in Greene County. Hence, the proliferation of these government initiatives is expected to drive the sexually transmitted infections (STIs) market growth. A rising trend in unprotected sex is anticipated to stimulate the growth of the STI market. This trend refers to a practice where individuals have sexual intercourse without using protective measures, such as condoms, thereby increasing the risk of STIs. For example, the World Health Organization, a UK-based intergovernmental organization, stated in August 2024 that the number of sexually active adolescents who used condoms during their most recent sexual intercourse had decreased in 2022. Statistical data showed a decline from 70% to 61% among boys and from 63% to 57% among girls. This rise in unprotected sex is thus fueling the expansion of the STIs market.

Which Companies Hold the Largest Share Across Different Sexually Transmitted Infections (STIs) Market Segments?
Major companies operating in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.

What Are the Latest Developing Trends in the Sexually Transmitted Infections (STIs) Market?
Key players in the sexually transmitted infections (STIs) market are leveraging innovative fluorescent PCR (Polymerase Chain Reaction) technology to gain a leading edge in the industry. This molecular biology method is capable of identifying and measuring certain DNA sequences in biological samples. For instance, Jiangsu Bioperfectus Technologies Co. Ltd., a Chinese molecular diagnostic solutions company, launched two new PCR kits in March 2023: the Mycoplasma Hominis Real-Time PCR Kit and the Treponema Pallidum Real-Time PCR Kit. These kits offer comprehensive PCR options for early STI detection, which affects numerous individuals. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit is a reagent utilizing fluorescent PCR technology to identify Mycoplasma hominis in human samples such as male urethral swabs, female cervical, vaginal swabs, and urine. The BioPerfectus Treponema Pallidum Real-Time PCR Kit is engineered to detect treponema pallidum nucleic acid in human serum and plasma.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/sexually-transmitted-infections-stis-global-market-report

What Are the Emerging Geographies for The Sexually Transmitted Infections (STIs) Market Growth?
North America was the largest region in the sexually transmitted infection (STIs) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Sexually Transmitted Infections (STIs) Market?
2. What is the CAGR expected in the Sexually Transmitted Infections (STIs) Market?
3. What Are the Key Innovations Transforming the Sexually Transmitted Infections (STIs) Industry?
4. Which Region Is Leading the Sexually Transmitted Infections (STIs) Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.